Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/3/2026

Treatment of Thoracic Vertebral Fractures in Patients with Chronic Steroid Use

Immediate Management

  • The American College of Physicians recommends starting acetaminophen as first-line analgesia, avoiding NSAIDs if cardiovascular or renal comorbidities exist, for patients with cracked thoracic vertebrae and chronic steroid use 1
  • The American Geriatrics Society suggests using short-term narcotic medications only if necessary for severe pain in patients with thoracic vertebral fractures and chronic steroid use 2
  • Avoid prolonged bed rest as it accelerates bone loss, muscle weakness, and increases risk of deep vein thrombosis and pressure ulcers in patients with thoracic vertebral fractures and chronic steroid use 1, 2
  • Begin early mobilization as tolerated to prevent complications of immobility in patients with thoracic vertebral fractures and chronic steroid use 2
  • Initiate range-of-motion exercises within the first postoperative days for patients with thoracic vertebral fractures and chronic steroid use 1

Rehabilitation Strategy

  • The American College of Sports Medicine recommends implementing early post-fracture physical training and muscle strengthening for patients with thoracic vertebral fractures and chronic steroid use 3, 2
  • Establish long-term balance training and multidimensional fall prevention programs, which reduce fall frequency by approximately 20%, for patients with thoracic vertebral fractures and chronic steroid use 3, 1
  • Identify individual goals and needs before developing the rehabilitation plan for patients with thoracic vertebral fractures and chronic steroid use 3, 2

Pharmacological Treatment for Osteoporosis Prevention

  • The National Osteoporosis Foundation recommends oral bisphosphonates (alendronate or risedronate) as the first-choice agents because they reduce vertebral, non-vertebral, and hip fractures, are well-tolerated, cost-effective, and widely available as generics for patients with thoracic vertebral fractures and chronic steroid use 3, 4, 2
  • Prescribe bisphosphonates for 3-5 years initially, with longer duration for patients who remain at high risk, for patients with thoracic vertebral fractures and chronic steroid use 3, 4
  • These agents demonstrated reduction in vertebral fractures, non-vertebral fractures, and hip fractures in primary analyses for patients with thoracic vertebral fractures and chronic steroid use 3, 4
  • The National Osteoporosis Foundation suggests calcium 1000-1200 mg/day plus vitamin D 800 IU/day reduces non-vertebral fractures by 15-20% and falls by 20% for patients with thoracic vertebral fractures and chronic steroid use 3, 4, 1, 2
  • Avoid high pulse dosages of vitamin D as they are associated with increased fall risk for patients with thoracic vertebral fractures and chronic steroid use 3, 4

Non-Pharmacological Interventions

  • The American Heart Association recommends smoking cessation and limiting alcohol intake to improve bone mineral density, bone quality, and reduce fall risk for patients with thoracic vertebral fractures and chronic steroid use 3, 4, 2
  • Implement weight-bearing exercise programs to improve BMD and muscle strength for patients with thoracic vertebral fractures and chronic steroid use 1
  • Address environmental hazards in the home for patients with thoracic vertebral fractures and chronic steroid use 1
  • Review medications that may increase fall risk for patients with thoracic vertebral fractures and chronic steroid use 1

Special Considerations for Steroid-Induced Fractures

  • Chronic steroid use contributes to poor outcomes through continued bone loss, poor nutritional status, immobilization effects, and direct bone quality effects for patients with thoracic vertebral fractures 5
  • Consider kyphoplasty for persistent pain despite conservative management, as it provides immediate pain relief, avoidance of delays in treatment, outpatient care in majority of cases, and vertebral height restoration for patients with thoracic vertebral fractures and chronic steroid use 5
  • The Cancer Patient Fracture Evaluation study demonstrated that kyphoplasty significantly improved functional status for patients with thoracic vertebral fractures and chronic steroid use 5

Monitoring and Follow-Up

  • Implement a five-step plan: identify patients with recent fracture, invite for fracture risk evaluation, perform differential diagnosis, initiate therapy, and establish follow-up for patients with thoracic vertebral fractures and chronic steroid use 3, 4
  • Monitor regularly for medication tolerance and adherence, as long-term adherence is typically poor for patients with thoracic vertebral fractures and chronic steroid use 3, 4, 2
  • Use risk communication and shared decision-making to improve adherence for patients with thoracic vertebral fractures and chronic steroid use 3, 4
  • Establish orthogeriatric co-management for frail elderly patients with multiple comorbidities and thoracic vertebral fractures 1, 2
  • Coordinate between orthopedic surgery, rheumatology/endocrinology, and primary care for patients with thoracic vertebral fractures and chronic steroid use 1

Critical Pitfalls to Avoid

  • Do not allow prolonged bed rest beyond what is absolutely necessary for acute pain control for patients with thoracic vertebral fractures and chronic steroid use 1, 2
  • Do not delay osteoporosis treatment in patients with confirmed vertebral fractures and chronic steroid use 2
  • Do not use calcium supplementation alone without vitamin D and bisphosphonates, as calcium alone has no demonstrated fracture reduction effect for patients with thoracic vertebral fractures and chronic steroid use 3, 4
  • Do not overlook the need for vertebral augmentation in patients with persistent pain despite conservative management and thoracic vertebral fractures 5, 2

Evidence‑Based Nutritional Management for Fracture Patients

Calcium and Vitamin D

  • Emphasize obtaining calcium primarily from calcium‑rich foods rather than relying on supplements, because the evidence that supplementation alone prevents fractures is weak. 6
  • Routine high‑dose calcium + vitamin D supplementation does not reduce the risk of subsequent hip or other fractures in older adults with a prior osteoporotic fracture; supplementation should be individualized based on risk‑benefit assessment. 7
  • A single loading (pulse) dose of vitamin D₃ given within the first week after a hip fracture markedly lowered fall rates (≈250 vs ≈820 falls per 1,000 patient‑days) in one randomized trial, but this approach requires careful patient‑specific risk‑benefit consideration. 7

Protein

  • Current evidence is insufficient to support routine oral protein supplementation for improving functional recovery after hip fracture. 8

Multicomponent Nutritional Interventions

  • Combining adequate nutrition, fall‑prevention strategies, and patient education as a multicomponent program improves outcomes for high‑risk fracture patients. 9

Lifestyle Modifications

  • Limit alcohol consumption to ≤2 units per day (≈50 g) because higher intake increases fracture risk through direct bone effects and greater fall propensity. 9
  • Enforce smoking cessation, as tobacco use consistently diminishes bone mass and raises the risk of osteoporotic fractures. 10

Special Populations

Older Adults (≥ 50 years)

  • Discussions should focus on the patient’s actual calcium and vitamin D intake versus recommended levels rather than automatically prescribing supplements. 11
  • Promote a healthy body weight, increased consumption of fresh fruits and vegetables, and reduced sodium intake to support bone health. 10

Chronic Kidney Disease (CKD)

  • Use calcium supplementation cautiously in CKD patients to avoid the risk of vascular calcification. 11
  • Tailor vitamin D formulation and dosing to the individual’s CKD stage, with close monitoring. 11

Integrated Care

  • Embedding nutritional management within multidisciplinary fracture‑liaison services reduces re‑fracture rates by roughly 30 % compared with usual care. 8

Calcium, Vitamin D, and Protein Supplementation for Rib Fracture Healing in Healthy Adults

Calcium and Vitamin D Supplementation

  • Calcium provides essential substrates for bone repair, while vitamin D enhances intestinal calcium absorption; together they support the physiological process of fracture healing. 12
  • The Institute of Medicine advises that healthy adults younger than 50 years should meet calcium and vitamin D needs through the Recommended Dietary Allowances rather than routine supplementation. [13][14]
  • In community‑dwelling adults without osteoporosis or vitamin D deficiency, routine calcium + vitamin D supplementation does not confer additional benefit for bone health. [15][16]
  • The U.S. Preventive Services Task Force reports that daily supplementation with 400 IU vitamin D₃ and 1 g calcium did not reduce fracture incidence in postmenopausal women, indicating limited efficacy for fracture prevention in low‑risk groups. [15][16]

Risks of Calcium/Vitamin D Supplementation

  • Calcium supplementation (≤1 g daily) combined with low‑dose vitamin D (≤400 IU) is associated with an increased risk of kidney stones, with an incidence of approximately one stone per 273 patients over seven years. [15][12]14

Protein Supplementation

  • Current evidence is insufficient to endorse routine oral protein supplementation for enhancing functional recovery after fractures; randomized trials have not shown clear functional benefits. 17

Assessment and Decision‑Making

  • Prior to prescribing supplements, clinicians should evaluate the patient’s dietary intake of calcium and vitamin D to determine adequacy. 17
  • When dietary intake already meets the target of 1 g–1.2 g calcium per day (from dairy, fortified foods, leafy greens, etc.), additional supplementation has not been proven beneficial in healthy adults. [15][16]
  • For patients with inadequate dietary calcium (<1 g/day) and vitamin D (<800 IU/day), supplementation to achieve 1 g–1.2 g calcium and 800 IU vitamin D daily may be considered, recognizing the limited evidence for direct impact on fracture healing.

Evidence Gaps and Population Considerations

  • The majority of data on calcium and vitamin D supplementation derive from studies of osteoporotic or elderly populations; evidence specific to healthy adults with acute rib fractures is sparse. [17][15]16
  • No high‑quality trials have evaluated the effect of calcium + vitamin D on the healing of rib fractures, only on fracture prevention. Consequently, recommendations are based on indirect evidence and expert consensus. 17

REFERENCES

1

Management of Osteoporosis in Elderly Patients with Comorbidities [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

Management of Vertebral Fractures [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025